milnacipran has been researched along with Depression in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (3.57) | 18.2507 |
| 2000's | 15 (53.57) | 29.6817 |
| 2010's | 10 (35.71) | 24.3611 |
| 2020's | 2 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Ikenouchi, A; Okamoto, N; Yoshimura, R | 1 |
| Hirose, E; Isoda, H; Ito, N; Nagai, T; Odaguchi, H; Sasaki, K | 1 |
| Ishibashi, T; Kawai, H; Kawashima, Y; Kudo, N; Machida, M; Mitsumoto, A | 1 |
| Ang, DC; Gracely, RH; Hilligoss, J; Jensen, MP; Saha, C; Steiner, JL | 1 |
| Assié, MB; Auclair, AL; Bardin, L; Cussac, D; Depoortère, R; Heusler, P; Marien, M; Martel, JC; Newman-Tancredi, A; O'Connor, JA | 1 |
| Albrecht, KL; Bernstein, CD; Marcus, DA | 1 |
| Abe, M; Mori, Y; Nakata, S; Ochi, S; Ueno, S; Yamazaki, K; Yoshino, Y | 1 |
| Chen, C; Gommoll, C; McIntyre, RS; Ruth, A | 1 |
| Koshiishi, T; Okuyama, K | 1 |
| Isaac, MT | 1 |
| Hanawa, T; Ito, N; Nagai, T; Oikawa, T; Yabe, T; Yamada, H | 1 |
| Doe, N; Kiriyama, M; Takahashi, T | 1 |
| Chou, SY; Hung, TH; Su, JA; Tsai, CS; Tsang, HY; Wu, CL | 1 |
| Ito, M; Kimura, H; Kurita, K; Nagashima, W; Ozaki, N; Tokura, T; Yoshida, K | 1 |
| Bouvard, M; Rénéric, JP; Stinus, L | 1 |
| Higuchi, H; Shimizu, T; Takahashi, H; Yoshida, K | 1 |
| Endo, S; Kanetani, K; Kimura, M | 1 |
| Bogolepova, AN; Gekht, AB; Gudkova, AA; Sorokina, IB | 1 |
| Arita, S; Morishita, S | 3 |
| Higuchi, H; Kamata, M; Shimizu, T; Takahashi, H; Yoshida, K | 1 |
| Asada, T; Ohta, H; Satoh, S; Sawa, S; Yamakawa, Y | 1 |
| Asada, T; Mizukami, K; Tanaka, Y | 1 |
| Higuchi, H; Inoue, K; Itoh, K; Kamata, M; Ozaki, N; Suzuki, T; Takahashi, H; Yoshida, K | 1 |
| Higuchi, H; Ozaki, N; Yoshida, K | 1 |
| Bolotov, AV; Izvozchikov, SB; Kaprin, AD; Selitskiĭ, GV; Troshina, AV | 1 |
| Autret-Leca, E; Bourgade, B; Ferquel, D; Jonville-Béra, AP; Le Garé, C | 1 |
2 review(s) available for milnacipran and Depression
| Article | Year |
|---|---|
Milnacipran for fibromyalgia: a useful addition to the treatment armamentarium.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Chronic Disease; Cyclopropanes; Depression; Fatigue; Fibromyalgia; Humans; Milnacipran; Pain Management; Selective Serotonin Reuptake Inhibitors; Weight Loss | 2013 |
Treating depression with SNRIs: who will benefit most?
Topics: Cyclopropanes; Cytochrome P-450 CYP2D6; Depression; Humans; Meta-Analysis as Topic; Methoxyhydroxyphenylglycol; Milnacipran; Pharmacogenetics; Polymorphism, Genetic; Selective Serotonin Reuptake Inhibitors | 2008 |
6 trial(s) available for milnacipran and Depression
| Article | Year |
|---|---|
Combining cognitive-behavioral therapy and milnacipran for fibromyalgia: a feasibility randomized-controlled trial.
Topics: Adolescent; Adult; Aged; Cognitive Behavioral Therapy; Cyclopropanes; Depression; Double-Blind Method; Feasibility Studies; Female; Fibromyalgia; Humans; Male; Middle Aged; Milnacipran; Outcome Assessment, Health Care; Pain Measurement; Pain Perception; Selective Serotonin Reuptake Inhibitors; Time Factors; Young Adult | 2013 |
Prevention of poststroke depression with milnacipran in patients with acute ischemic stroke: a double-blind randomized placebo-controlled trial.
Topics: Aged; Cyclopropanes; Depression; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Milnacipran; Stroke; Treatment Outcome | 2011 |
Differential effects of fluvoxamine, paroxetine and milnacipran for depression, especially with regard to age.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Chi-Square Distribution; Cohort Studies; Cyclopropanes; Depression; Female; Fluvoxamine; Humans; Male; Middle Aged; Milnacipran; Paroxetine; Psychiatric Status Rating Scales; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2004 |
Efficacy of milnacipran on poststroke depression on inpatient rehabilitation.
Topics: Activities of Daily Living; Affect; Aged; Antidepressive Agents; Cyclopropanes; Depression; Female; Humans; Male; Middle Aged; Milnacipran; Psychiatric Status Rating Scales; Quality of Life; Stroke; Stroke Rehabilitation; Surveys and Questionnaires; Treatment Outcome | 2005 |
Efficacy of milnacipran on the depressive state in patients with Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cyclopropanes; Depression; Female; Humans; Male; Middle Aged; Milnacipran; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome | 2006 |
The G196A polymorphism of the brain-derived neurotrophic factor gene and the antidepressant effect of milnacipran and fluvoxamine.
Topics: Adult; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Cyclopropanes; Depression; Exons; Female; Fluvoxamine; Gene Frequency; Genotype; Humans; Male; Middle Aged; Milnacipran; Patient Compliance; Patient Selection; Phenotype; Polymorphism, Genetic; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Time Factors; Treatment Outcome | 2007 |
20 other study(ies) available for milnacipran and Depression
| Article | Year |
|---|---|
Effect of Milnacipran on Plasma Level of Vascular Endothelial Growth Factor in Major Depression.
Topics: Antidepressive Agents; Cyclopropanes; Depression; Depressive Disorder, Major; Humans; Milnacipran; Selective Serotonin Reuptake Inhibitors; Vascular Endothelial Growth Factor A | 2022 |
Preventive effect of a Kampo medicine, kososan, on recurrent depression in a mouse model of repeated social defeat stress.
Topics: Administration, Oral; Animals; Antidepressive Agents; Depression; Disease Models, Animal; Drugs, Chinese Herbal; Gene Expression Profiling; Gene Expression Regulation; Gene Ontology; Hippocampus; Japan; Male; Medicine, Kampo; Mice; Mice, Inbred BALB C; Milnacipran; Molecular Sequence Annotation; Nerve Tissue Proteins; Oligonucleotide Array Sequence Analysis; Recurrence; Social Defeat; Stress, Psychological | 2022 |
Chronopharmacological Analysis of Antidepressant Activity of a Dual-Action Serotonin Noradrenaline Reuptake Inhibitor (SNRI), Milnacipran, in Rats.
Topics: Administration, Oral; Adrenergic Neurons; Animals; Antidepressive Agents; Behavior, Animal; Brain; Chronopharmacokinetics; Circadian Rhythm; Cyclopropanes; Depression; Dose-Response Relationship, Drug; Drug Administration Schedule; Hippocampus; Male; Milnacipran; Norepinephrine; Rats; Rats, Wistar; Serotonergic Neurons; Serotonin and Noradrenaline Reuptake Inhibitors; Tissue Distribution | 2018 |
Levomilnacipran (F2695), a norepinephrine-preferring SNRI: profile in vitro and in models of depression and anxiety.
Topics: Adrenergic Uptake Inhibitors; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Behavior, Animal; Cerebral Cortex; Cyclohexanols; Cyclopropanes; Depression; Dopamine; Duloxetine Hydrochloride; Humans; Male; Mice; Milnacipran; Motor Activity; Neurotransmitter Transport Proteins; Norepinephrine; Rats; Serotonin; Synaptosomes; Thiophenes; Venlafaxine Hydrochloride | 2013 |
Antidepressant action via the nitric oxide system: A pilot study in an acute depressive model induced by arginin.
Topics: Acute Disease; Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Arginine; Cyclopropanes; Depression; Fluoxetine; Male; Mianserin; Milnacipran; Mirtazapine; Nitric Oxide; Nitric Oxide Synthase; Pilot Projects; Rats, Wistar; Selective Serotonin Reuptake Inhibitors | 2015 |
The efficacy of levomilnacipran ER across symptoms of major depressive disorder: a post hoc analysis of 5 randomized, double-blind, placebo-controlled trials.
Topics: Adult; Anhedonia; Anorexia; Antidepressive Agents; Clinical Trials, Phase III as Topic; Cyclopropanes; Delayed-Action Preparations; Depression; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Milnacipran; Randomized Controlled Trials as Topic; Suicidal Ideation; Treatment Outcome | 2016 |
Probable Serotonin Syndrome and Withdrawal Symptoms Caused by Milnacipran.
Topics: Aged; Antidepressive Agents; Cerebral Hemorrhage; Cyclopropanes; Depression; Drug Substitution; Female; Humans; Mianserin; Milnacipran; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Substance Withdrawal Syndrome; Treatment Outcome | 2016 |
A possible mechanism underlying an antidepressive-like effect of Kososan, a Kampo medicine, via the hypothalamic orexinergic system in the stress-induced depression-like model mice.
Topics: Animals; Bromodeoxyuridine; Cell Proliferation; Cyclopropanes; Depression; Disease Models, Animal; Drugs, Chinese Herbal; Hippocampus; Hypothalamus; Intracellular Signaling Peptides and Proteins; Magnoliopsida; Male; Medicine, Kampo; Mice; Mice, Inbred Strains; Milnacipran; Neuropeptide Y; Neuropeptides; Neurotransmitter Agents; Norepinephrine; Orexins; Phytotherapy; Selective Serotonin Reuptake Inhibitors; Serotonin; Stress, Psychological | 2009 |
Behavioral despair during a water maze learning task in mice.
Topics: Animals; Behavior, Animal; Cyclopropanes; Depression; Disease Models, Animal; Escape Reaction; Fluvoxamine; Male; Maze Learning; Memory; Mice; Mice, Inbred C57BL; Milnacipran; Selective Serotonin Reuptake Inhibitors; Swimming | 2010 |
Plasma levels of milnacipran and its effectiveness for the treatment of chronic pain in the orofacial region.
Topics: Adult; Aged; Antidepressive Agents; Chronic Pain; Cyclopropanes; Depression; Dose-Response Relationship, Drug; Facial Pain; Female; Humans; Male; Middle Aged; Milnacipran; Pain Measurement; Retrospective Studies; Statistics as Topic; Young Adult | 2012 |
In the rat forced swimming test, chronic but not subacute administration of dual 5-HT/NA antidepressant treatments may produce greater effects than selective drugs.
Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Clonidine; Cyclopropanes; Depression; Desipramine; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; Male; Mianserin; Milnacipran; Mirtazapine; Motor Activity; Norepinephrine; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Selective Serotonin Reuptake Inhibitors; Swimming | 2002 |
Favorable effect of milnacipran on depression induced by interferon-alpha.
Topics: Aged; Cyclopropanes; Depression; Dose-Response Relationship, Drug; Humans; Interferon alpha-2; Interferon-alpha; Male; Milnacipran; Recombinant Proteins; Selective Serotonin Reuptake Inhibitors | 2003 |
Therapeutic effects of milnacipran (serotonin noradrenalin reuptake inhibitor) on depression following mild and moderate traumatic brain injury.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Antidepressive Agents; Brain Injuries; Cyclopropanes; Depression; Drug Evaluation; Female; Humans; Male; Middle Aged; Milnacipran; Selective Serotonin Reuptake Inhibitors | 2003 |
[Experience with ixel (milnacipran hydrochloride) use in the treatment of patients with post-stroke depression].
Topics: Adult; Aged; Antidepressive Agents; Case-Control Studies; Cyclopropanes; Depression; Female; Humans; Male; Middle Aged; Milnacipran; Severity of Illness Index; Stroke; Treatment Outcome | 2003 |
Prevalence of induced mania in patients treated with milnacipran: a comparison with paroxetine.
Topics: Adult; Aged; Bipolar Disorder; Cohort Studies; Cyclopropanes; Depression; Female; Humans; Male; Middle Aged; Milnacipran; Paroxetine; Prevalence; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Surveys and Questionnaires | 2004 |
Differential effects of milnacipran, fluvoxamine and paroxetine for inhibited and agitated depression.
Topics: Cohort Studies; Cyclopropanes; Depression; Drug Administration Schedule; Fluvoxamine; Humans; Milnacipran; Paroxetine; Psychomotor Agitation; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Surveys and Questionnaires | 2004 |
Remarkable effect of milnacipran, a serotonin-noradrenalin reuptake inhibitor (SNRI), on depressive symptoms in patients with Parkinson's disease who have insufficient response to selective serotonin reuptake inhibitors (SSRIs): two case reports.
Topics: Adrenergic Uptake Inhibitors; Cyclopropanes; Depression; Female; Humans; Male; Middle Aged; Milnacipran; Parkinson Disease; Selective Serotonin Reuptake Inhibitors | 2005 |
Successful treatment of severe antidepressant-induced nausea with a combination of milnacipran and olanzapine.
Topics: Adult; Antidepressive Agents; Benzodiazepines; Cyclopropanes; Depression; Drug Therapy, Combination; Female; Humans; Milnacipran; Nausea; Obsessive-Compulsive Disorder; Olanzapine; Selective Serotonin Reuptake Inhibitors | 2007 |
[Milnacipran (ixel) in the treatment of anxiodepressive and sexual disorders in patients with noninflammatory syndrome of chronic pelvic pain].
Topics: Adult; Antidepressive Agents; Anxiety; Cyclopropanes; Depression; Humans; Male; Milnacipran; Pelvic Pain; Sexual Dysfunctions, Psychological; Treatment Outcome | 2007 |
Raynaud's syndrome in a patient treated with milnacipran.
Topics: Adult; Antidepressive Agents; Cyclopropanes; Depression; Female; Humans; Milnacipran; Raynaud Disease; Selective Serotonin Reuptake Inhibitors | 1999 |